HOWL Q3 2023 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$35M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+18.7% YoY

Gross Profit

$5M92.5% margin

Operating Income

-$9M-156.9% margin

Net Income

-$8M-140.5% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-27.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$176M

Total Liabilities

$64M

Stockholders' Equity

$112M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+18.7%
Gross Profit	$5M	$4M	+27.9%
Operating Income	-$9M	-$13M	+26.2%
Net Income	-$8M	-$12M	+30.6%